We did observe loss of CXCR3 in tumor-infiltrating CD8+ T cells from both WT and ALK5ΔCD8 animals suggesting that exhaustion is occurring through TGFβ-independent mechanisms, and may provide an opportunity for synergy with immune therapies targeting exhaustion, such as immune checkpoint blockade. The gene discussed is CD8A; the disease is neoplasm.